GUAIFENESIN
NDC 70010-199, GUAIFENESIN, tablet, extended release, from GRANULES PHARMACEUTICALS INC..
- Product NDC
- 70010-199
- Status
- Listed
- Labeler
- GRANULES PHARMACEUTICALS INC.
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA213420
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70010-199 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GUAIFENESIN600 mg/1
Pharmacologic classes
Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70010-199-05 | 70010019905 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (70010-199-05) |
Linked data
RxNorm, label and prices
Related lookups
NADAC price for package 70010019905
GET /v1/drugs/nadac/70010019905
Use it
Look up 70010-199 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70010-199 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70010-199. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.